Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2003 | 09-2003 | 06-2003 | 03-2003 | 12-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 280 | 270 | 320 | 70 | 430 |
| Marketable Securities | 1,300 | 1,650 | 2,090 | 3,040 | 3,130 |
| Other current assets | 60 | 160 | 190 | 180 | 230 |
| TOTAL | $1,640 | $2,080 | $2,600 | $3,290 | $3,790 |
| Non-Current Assets | |||||
| Investments And Advances | 7 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 740 | 637 | 577 | 467 | 407 |
| TOTAL | $747 | $637 | $577 | $467 | $407 |
| Total Assets | $2,460 | $2,790 | $3,260 | $3,840 | $4,270 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 20 | 30 | 50 | 60 | 40 |
| Accrued Expenses | 400 | 370 | 260 | 360 | 290 |
| TOTAL | $430 | $400 | $310 | $420 | $340 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 90 | 90 | 90 | 90 | 70 |
| TOTAL | $90 | $90 | $90 | $90 | $70 |
| Total Liabilities | $520 | $490 | $400 | $510 | $420 |
| Shareholders' Equity | |||||
| Common Shares | 120 | 110 | 110 | 110 | 110 |
| Retained earnings | -11,690 | -10,890 | -9,490 | -9,020 | -8,500 |
| Other shareholders' equity | 0 | 10 | 0 | 10 | 0 |
| TOTAL | $1,940 | $2,300 | $2,850 | $3,330 | $3,840 |
| Total Liabilities And Equity | $2,460 | $2,790 | $3,250 | $3,840 | $4,260 |